
72.01 Delayed Data As of Dec 01 | ![]() Today’s Change | 37.82 Today|||52-Week Range 72.14 | +64.37% Year-to-Date |
Why Is Glaxo (GSK) Up 5.3% Since Last Earnings Report? Dec 01 / Zacks.com - Paid Partner Content | Why Is Deciphera Pharmaceuticals, Inc. (DCPH) Up 1.7% Since Last Earnings Report? Nov 29 / Zacks.com - Paid Partner Content |
Repligen (RGEN) Up 21.3% Since Last Earnings Report: Can It Continue? Nov 30 / Zacks.com - Paid Partner Content |
Previous close | 69.64 |
Today’s open | 68.87 |
Day’s range | 68.30 - 72.02 |
Volume | 21,222 |
Average volume (3 months) | 682,928 |
Market cap | $4.3B |
Earnings growth (last year) | +15.07% |
Earnings growth (this year) | -3.58% |
Earnings growth (next 5 years) | +34.00% |
Revenue growth (last year) | +13.30% |
P/E ratio | NM |
Price/Sales | 12.81 |
Price/Book | 8.33 |
Next reporting date | February 15, 2024 |
EPS forecast (this quarter) | -$2.47 |
Annual revenue (last year) | $204.0M |
Annual profit (last year) | -$557.5M |
Net profit margin | -273.24% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |